Altered functioning of both renal dopamine d1 and angiotensin ii type 1 receptors causes hypertension in old rats

Hypertension

Volumn 59, Issue 5, 2012, Pages 1029-1036

  Chugh, Gaurav ^a   Lokhandwala, Mustafa F ^a   Asghar, Mohammad ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Aging; Angiotensin; Blood pressure; Dopamine; Oxidative stress; Sodium

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; DOPAMINE 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 4; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); TEMPOL;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURESIS; ENZYME ACTIVITY; EXPERIMENTAL RAT; FISCHER BROWN NORWAY F1 RAT; HYPERTENSION; KIDNEY PROXIMAL TUBULE; MALE; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN FUNCTION; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; AGING; ANIMALS; BINDING SITES; CYCLIC N-OXIDES; DISEASE MODELS, ANIMAL; HYPERTENSION; KIDNEY TUBULES, PROXIMAL; MALE; OXIDATIVE STRESS; PROTEIN BINDING; RANDOM ALLOCATION; RATS; RATS, INBRED F344; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, DOPAMINE D1; REFERENCE VALUES; RISK FACTORS; SPIN LABELS;

EID: 84860221324     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.192302     Document Type: Article

References (54)

1. Gildea JJ. Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance. Curr Opin Nephrol Hypertens. 2009;18: 28-32.
2. Carey RM. Theodore Cooper Lecture: renal dopamine system-paracrine regulator of sodium homeostasis and blood pressure. Hypertension. 2001; 38:297-302. (Pubitemid 34225655)
3. Hussain T, Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood). 2003;228:134-142. (Pubitemid 36187919)
4. Jose PA, Eisner GM, Felder RA. Renal dopamine and sodium homeostasis. Curr Hypertens Rep. 2000;2:174-183.
5. Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signalling and function. Blood Press. 2003;12:70-88. (Pubitemid 36700689)
6. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal reninangiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251-287. (Pubitemid 47481436)
7. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007;292:C82-C97. (Pubitemid 46127306)
8. Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, Sibley DR, Westphal HJ, Jose PA. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest. 1996;97: 2283-2288.
9. Chen C, Beach RE, Lokhandwala MF. Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension. 1993;21: 364-372. (Pubitemid 23065177)
10. Chen CJ, Lokhandwala MF. An impairment of renal tubular DA-1 receptor function as the causative factor for diminished natriuresis to volume expansion in spontaneously hypertensive rats. Clin Exp Hypertens A. 1992;14:615-628.
11. Damasceno A, Santos A, Serrao P, Caupers P, Soares-da-Silva P, Polonia J. Deficiency of renal dopaminergic-dependent natriuretic response to acute sodium load in black salt-sensitive subjects in contrast to saltresistant subjects. J Hypertens. 1999;17:1995-2001. (Pubitemid 30345343)
12. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension. 1990;15:560-569. (Pubitemid 20187600)
13. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther. 1998;80:149-182. (Pubitemid 28498226)
14. Zeng C, Eisner GM, Felder RA, Jose PA. Dopamine receptor and hypertension. Curr Med Chem Cardiovasc Hematol Agents. 2005;3:69-77. (Pubitemid 40057733)
15. Banday AA, Lokhandwala MF. Oxidative stress-induced renal angiotensin AT1 receptor upregulation causes increased stimulation of sodium transporters and hypertension. Am J Physiol Renal Physiol. 2008;295: F698-F706.
16. Shah S, Hussain T. Enhanced angiotensin II-induced activation of Nä, Kγ-ATPase in the proximal tubules of obese Zucker rats. Clin Exp Hypertens. 2006;28:29-40. (Pubitemid 43200782)
17. Najjar SS, Scuteri A, Lakatta EG. Arterial aging: is it an immutable cardiovascular risk factor? Hypertension. 2005;46:454-462. (Pubitemid 41376818)
18. Pestana M. Hypertension in the elderly. Int Urol Nephrol. 2001;33: 563-569.
19. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287:1003-1010. (Pubitemid 34252058)
20. Epstein M. Aging and the kidney. J Am Soc Nephrol. 1996;7:1106-1122. (Pubitemid 27468261)
21. Percy CJ, Power D, Gobe GC. Renal ageing: changes in the cellular mechanism of energy metabolism and oxidant handling. Nephrology (Carlton). 2008;13:147-152. (Pubitemid 351229633)
22. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA. 1993;90: 7915-7922. (Pubitemid 23260825)
23. Beheray S, Kansra V, Hussain T, Lokhandwala MF. Diminished natriuretic response to dopamine in old rats is due to an impaired D1-like receptor-signaling pathway. Kidney Int. 2000;58:712-720. (Pubitemid 30620020)
24. Zemel MB, Sowers JR. Salt sensitivity and systemic hypertension in the elderly. Am J Cardiol. 1988;61:7H-12H.
25. Baylis C. Renal responses to acute angiotensin II inhibition and administered angiotensin II in the aging, conscious, chronically catheterized rat. Am J Kidney Dis. 1993;22:842-850. (Pubitemid 23353617)
26. White BH, Sidhu A. Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/G-protein coupling. J Hypertens. 1998;16: 1659-1665. (Pubitemid 28515493)
27. Becker M, Umrani D, Lokhandwala MF, Hussain T. Increased renal angiotensin II AT1 receptor function in obese Zucker rat. Clin Exp Hypertens. 2003;25:35-47. (Pubitemid 36194018)
28. Banday AA, Marwaha A, Tallam LS, Lokhandwala MF. Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats. Diabetes. 2005;54: 2219-2226. (Pubitemid 40911287)
29. Javkhedkar AA, Lokhandwala MF, Banday AA. Higher renal AT1 receptor affinity exaggerates Ang II induced Na/K-ATPase stimulation in spontaneously hypertensive rats [abstract]. FASEB J. 2010;24(suppl): lb707.
30. Chugh G, Lokhandwala MF, Asghar M. Oxidative stress alters renal D1 and AT1 receptor functions and increases blood pressure in old rats. Am J Physiol Renal Physiol. 2011;300:F133-F138.
31. Marwaha A, Banday AA, Lokhandwala MF. Reduced renal dopamine D1 receptor function in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol. 2004;286:F451-F457. (Pubitemid 38233637)
32. Fardoun RZ, Asghar M, Lokhandwala M. Role of oxidative stress in defective renal dopamine D1 receptor-G protein coupling and function in old Fischer 344 rats. Am J Physiol Renal Physiol. 2006;291:F945-F951. (Pubitemid 44772027)
33. Hilf G, Gierschik P, Jakobs KH. Muscarinic acetylcholine receptorstimulated binding of guanosine 5=-O-(3-thiotriphosphate) to guaninenucleotide-binding proteins in cardiac membranes. Eur J Biochem. 1989; 186:725-731. (Pubitemid 20030128)
34. Banday AA, Lokhandwala MF. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptornitric oxide signaling. Hypertension. 2008;52:1099-1105.
35. Wilcox CS, Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev. 2008;60:418-469.
36. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, Felder RA. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension. 1999;33:1036-1042. (Pubitemid 29186405)
37. Kim OJ, Gardner BR, Williams DB, Marinec PS, Cabrera DM, Peters JD, Mak CC, Kim KM, Sibley DR. The role of phosphorylation in D1 dopamine receptor desensitization: evidence for a novel mechanism of arrestin association. J Biol Chem. 2004;279:7999-8010. (Pubitemid 38294688)
38. Rankin ML, Marinec PS, Cabrera DM, Wang Z, Jose PA, Sibley DR. The D1 dopamine receptor is constitutively phosphorylated by G proteincoupled receptor kinase 4. Mol Pharmacol. 2006;69:759-769. (Pubitemid 43363850)
39. Tiberi M, Nash SR, Bertrand L, Lefkowitz RJ, Caron MG. Differential regulation of dopamine D1A receptor responsiveness by various G protein-coupled receptor kinases. J Biol Chem. 1996;271:3771-3778. (Pubitemid 26065697)
40. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA. 2002;99:3872-3877. (Pubitemid 34252198)
41. Premont RT, Macrae AD, Stoffel RH, Chung N, Pitcher JA, Ambrose C, Inglese J, MacDonald ME, Lefkowitz RJ. Characterization of the G protein-coupled receptor kinase GRK4: identification of four splice variants. J Biol Chem. 1996;271:6403-6410.
42. Watanabe H, Xu J, Bengra C, Jose PA, Felder RA. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4. Kidney Int. 2002;62:790-798. (Pubitemid 35316708)
43. Jose PA, Soares-da-Silva P, Eisner GM, Felder RA. Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta. 1802:1259-1267.
44. Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Watanabe T, Moore JH, Ritchie MD, Williams SM, Pezzullo JC, Sasaki M, Eisner GM, Jose PA, Felder RA. Single-nucleotide polymorphisms for diagnosis of saltsensitive hypertension. Clin Chem. 2006;52:352-360.
45. Felder RA, Jose PA. Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol. 2006;2:637-650. (Pubitemid 44655641)
46. Ullian ME, Gelasco AK, Fitzgibbon WR, Beck CN, Morinelli TA. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells. J Am Soc Nephrol. 2005;16:2346-2353. (Pubitemid 41725052)
47. Ullian ME, Beck CN, Walker LP, Fitzgibbon WR, Morinelli TA. Thiol antioxidants regulate angiotensin II AT1 and arginine vasopressin V1 receptor functions differently in vascular smooth muscle cells. Am J Hypertens. 2009;22:221-227.
48. Leclerc PC, Proulx CD, Arguin G, Belanger S, Gobeil F Jr, Escher E, Leduc R, Guillemette G. Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II. Am J Hypertens. 2008;21:67-71.
49. Padia SH, Howell NL, Siragy HM, Carey RM. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension. 2006;47:537-544. (Pubitemid 43843872)
50. Padia SH, Kemp BA, Howell NL, Fournie-Zaluski MC, Roques BP, Carey RM. Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats. Hypertension. 2008;51: 460-465. (Pubitemid 351156433)
51. Padia SH, Kemp BA, Howell NL, Siragy HM, Fournie-Zaluski MC, Roques BP, Carey RM. Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptorblocked rats. Hypertension. 2007;49:625-630.
52. Padia SH, Kemp BA, Howell NL, Gildea JJ, Keller SR, Carey RM. Intrarenal angiotensin III infusion induces natriuresis and angiotensin type 2 receptor translocation in Wistar-Kyoto but not in spontaneously hypertensive rats. Hypertension. 2009;53:338-343.
53. Sanada H, Jones JE, Jose PA. Genetics of salt-sensitive hypertension. Curr Hypertens Rep. 13:55-66.
54. Baines RJ, Brunskill NJ. Tubular toxicity of proteinuria. Nat Rev Nephrol. 7:177-180.